Login / Signup
Commentary on Kahrass et al: The sublime inertia of informed consent language in early phase clinical trials involving patients.
Jonathan Kimmelman
Published in:
Clinical trials (London, England) (2020)
Keyphrases
</>
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
autism spectrum disorder
prognostic factors
peritoneal dialysis
patient reported